Share on StockTwits

Shire PLC (LON:SHP)‘s stock had its “market perform” rating reiterated by Sanford C. Bernstein in a research note issued on Wednesday. They currently have a GBX 3,700 ($63.02) target price on the stock. Sanford C. Bernstein’s price target would indicate a potential downside of 17.96% from the company’s current price.

A number of other firms have also recently commented on SHP. Analysts at AlphaValue reiterated a “reduce” rating on shares of Shire PLC in a research note on Friday, June 27th. They now have a GBX 4,599 ($78.33) price target on the stock. Separately, analysts at Kepler Capital Markets initiated coverage on shares of Shire PLC in a research note on Thursday, June 26th. They set a “buy” rating and a GBX 5,100 ($86.87) price target on the stock. Finally, analysts at Cowen and Company reiterated an “outperform” rating on shares of Shire PLC in a research note on Wednesday, June 25th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of GBX 3,297.64 ($56.17).

Shares of Shire PLC (LON:SHP) opened at 4521.00 on Wednesday. Shire PLC has a 1-year low of GBX 2069.00 and a 1-year high of GBX 4686.022. The stock has a 50-day moving average of GBX 3695. and a 200-day moving average of GBX 3234.. The company’s market cap is £26.416 billion.

Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.